Dueling Fools: Nuance Bull Rebuttal
Let's focus on the big picture, people.
Dueling Fools: Nuance Bull
A clear-cut defense of Nuance.
Megagrowth at Meridian Bioscience
The biotech produces another quarter of record revenue and earnings.
SurModics Serves Up a Big Quarter
The company reports record revenue and operating cash flow.
Cardinal Has Its Wings Clipped
Quarterly revenue increase of 5% isn't enough to satisfy investors.
Earnings Soar, Uncertainty Looms at WellCare
Third-quarter revenue rises 41.7%, but investigations continue.
5 Health-Care Stocks: Bargain or Bust?
They have strong earnings growth and are well off their 52-week highs. Should you buy?
Still Fit at Cigna
Earnings growth continues, complemented by a big buyback in the third quarter.
Successful Transitions at Molina
The managed-care provider gets rid of what isn't working and builds upon what is.
Is Forest Labs' Nebivolol Ready for Prime Time?
A Fool's prediction on the FDA's impending decision on approval.
Carolina Group Continues to Roll Up Profits
The tobacco company reports a year-over-year increase of 5.9% in Q3 net sales.
5 Top Health-Care and Biotech Stocks
Five stocks in the health-care sector that are poised for growth.
Tarceva Sales Thrive at OSI
The pharmaceutical's net revenue jumps 77%.
The Drag on Reynolds American
The tobacco company reports adjusted EPS growth of 12% versus its year-ago quarter.
A+ for Aetna
Strong operating earnings and membership growth push Aetna shares up.
A Quarter to Boast About at Bristol
Bristol-Myers announces a 22% rise in Q3 revenue as Plavix sales continue to rise.
Things Get Ugly at WellCare
Shares tumble after the FBI raids company HQ.
WellPoint Well on Its Way
A Q3 operating revenue increase of 5.2% is just one bit of good news for shareholders.
Plenty of Strength in Zimmer
Zimmer lowers its forecast for the fourth quarter, but reports a solid Q3.
Dueling Fools: Blue Nile Bull
The online jeweler's customer-friendly buying experience has succeeded in making the company a financial success.